EarningsQ1 2025 Earnings Report

Jazz Pharmaceuticals (JAZZN) Q1 2025 Earnings Report

0 Followers

MX:JAZZN Q1 2025 EPS Results

Actual EPS$30.87

Consensus EPS$85.59

Beat/MissMissed by -$54.72

One Year Ago EPS$49.24

Actual Revenue$16.50B

Expected Revenue$18.08B

Beat/MissMissed by -$1.58B

YoY Revenue Growth-0.46%

QuarterQ1 2025

Date05/06/2025

TimeAfter Close

Conference CallTuesday, May 6, 2025

MX:JAZZN Upcoming Earnings

Jazz Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:JAZZN Q1 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	115.78 / -	149.383	―
Aug 03, 2026	2026 (Q2)	113.46 / 104.92	-151.588	169.21% (+256.50)
May 05, 2026	2026 (Q1)	85.27 / 116.49	30.869	277.38% (+85.62)
Feb 24, 2026	2025 (Q4)	119.76 / 122.00	121.27	0.61% (+0.73)
Nov 05, 2025	2025 (Q3)	109.25 / 149.38	121.454	23.00% (+27.93)
Aug 05, 2025	2025 (Q2)	-139.75 / -151.59	97.384	-255.66% (-248.97)
May 06, 2025	2025 (Q1)	85.59 / 30.87	49.243	-37.31% (-18.37)
Feb 25, 2025	2024 (Q4)	107.71 / 121.27	92.239	31.47% (+29.03)
Nov 06, 2024	2024 (Q3)	101.02 / 121.45	88.931	36.57% (+32.52)
Jul 31, 2024	2024 (Q2)	90.44 / 97.38	82.868	17.52% (+14.52)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed